Skip to content
Search

Latest Stories

COVID-19: Deaths near 2,000 in India

The death toll due to COVID-19 rose to 1,886 and the number of cases climbed to 56,342 in India on Friday (8). The country reported 3,390 new cases and 103 deaths in the last 24 hours, according to the health ministry.

The number of active COVID-19 cases stood at 37,916. While 16,539 people have recovered, one patient has migrated, it said. Data shows that around 29.35 per cent patients have recovered so far in India.


The total cases include 111 foreign nationals.  Of the 103 deaths reported since Thursday (7) morning include 43 in Maharashtra; 29 in Gujarat; eight in Madhya Pradesh; seven in West Bengal; five in Rajasthan; two each in Tamil Nadu, Uttar Pradesh and Andhra Pradesh; and one each in Bihar, Delhi, Karnataka, Punjab and Jammu and Kashmir.

Of the 1,886 fatalities, Maharashtra tops the tally with 694 fatalities, Gujarat comes second with 425 deaths, followed by Madhya Pradesh at 193, West Bengal at 151, Rajasthan at 97, Delhi at 66, Uttar Pradesh at 62 and Andhra Pradesh at 38.

The death toll reached 37 in Tamil Nadu, 30 in Karnataka while Telengana has reported 29 fatalities due to the respiratory disease. Punjab has registered 28 COVID-19 deaths, Jammu and Kashmir nine, Haryana seven, Bihar five and Kerala four.  Jharkhand has recorded three COVID-19 fatalities. Odisha and Himachal Pradesh have reported two deaths each. Meghalaya, Chandigarh, Assam and Uttarakhand have reported one fatality each, according to the ministry data.

The highest number of confirmed cases in the country is from Maharashtra at 17,974 followed by Gujarat (7,012), Delhi (5,980), Tamil Nadu (5,409), Rajasthan (3,427), Madhya Pradesh (3,252) and Uttar Pradesh (3,071).

The number of COVID-19 cases has gone up to 1,847 in Andhra Pradesh and 1,644 in Punjab.   The tally has risen to 1,548 in West Bengal, 1,123 in Telangana, 793 in Jammu and Kashmir, 705 in Karnataka, 625 in Haryana and 550 in Bihar.   Kerala has reported 503 coronavirus cases so far, while Odisha has 219 infections.

A total of 135 people have been infected with the virus in Chandigarh and 132 in Jharkhand.     Tripura has reported 65 cases, Uttarakhand has 61, Chhattisgarh has 59, Assam has 54, Himachal Pradesh has 46 and Ladakh has 42.  Thirty-three COVID-19 cases have been reported from the Andaman and Nicobar Islands.  Meghalaya has registered 12 cases, Puducherry has nine, while Goa has seven.    Manipur has two cases. Mizoram, Arunachal Pradesh and Dadar and Nagar Haveli have reported one case each.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less